title: Histaminergic ligands injected into the nucleus basalis magnocellularis differentially affect fear conditioning consolidation.
abstract: The role of the nucleus basalis magnocellularis (NBM) in fear conditioning encoding is well established. In the present report, we investigate the involvement of the NBM histaminergic system in consolidating fear memories. The NBM was injected bilaterally with ligands of histaminergic receptors immediately after contextual fear conditioning. Histaminergic compounds, either alone or in combination, were stereotaxically administered to different groups of adult male Wistar rats and memory was assessed as conditioned freezing duration 72 h after administration. This protocol prevents interference with NBM function during either acquisition or retrieval phases, hence restricting the effect of pharmacological manipulations to fear memory consolidation. The results presented here demonstrate that post-training H3 receptors (H3R) blockade with the antagonist/inverse agonist thioperamide or activation with immepip in the NBM potentiates or decreases, respectively, freezing response at retrieval. Thioperamide induced memory enhancement seems to depend on H2R, but not H1R activation, as the H2R antagonist zolantidine blocked the effect of thioperamide, whereas the H1R antagonist pyrilamine was ineffective. Furthermore, the H2R agonist ampthamine improved fear memory expression independently of the H3R agonist effect. Our results indicate that activation of post-synaptic H2R within the NBM by endogenous histamine is responsible for the potentiated expression of fear responses. The results are discussed in terms of activation of H3 auto- and heteroreceptors within the NBM and the differential effect of H3R ligands on fear memory consolidation in distinct brain regions.
authors.affiliation: Dipartimento di Scienze Fisiologiche, Università di Firenze, Viale Morgagni, Firenze, Italy.
authors.forename: Fernando
authors.initials: F
authors.lastname: Benetti
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Baldi
authors.forename: Corrado
authors.initials: C
authors.lastname: Bucherelli
authors.forename: Patrizio
authors.initials: P
authors.lastname: Blandina
authors.forename: Maria Beatrice
authors.initials: MB
authors.lastname: Passani
mesh_terms: D000818:Animals; D020532:Basal Nucleus of Meynert / Q000187:drug effects / Q000378:metabolism*; D003213:Conditioning, Psychological / Q000187:drug effects / Q000502:physiology*; D005239:Fear / Q000187:drug effects / Q000502:physiology*; D017442:Histamine Agonists / Q000008:administration & dosage / Q000378:metabolism*; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000378:metabolism*; D007276:Injections, Intraventricular; D008024:Ligands; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D018100:Receptors, Histamine H3 / Q000378:metabolism*
chemical_list: D017442:Histamine Agonists; D006633:Histamine Antagonists; D008024:Ligands; D018100:Receptors, Histamine H3